Nuclear expression of YB-1 was detected in 60% (24/40 positive) of clear cell renal cell carcinomas, whereas DbpA expression was present in 92.5% (n = 37/40) of the analyzed tissue samples. Here, YBX3 is linked to clear cell renal carcinoma.